Kimelman & Baird, LLC Amgen Inc Transaction History
Kimelman & Baird, LLC
- $1.21 Trillion
- Q2 2024
A detailed history of Kimelman & Baird, LLC transactions in Amgen Inc stock. As of the latest transaction made, Kimelman & Baird, LLC holds 16,400 shares of AMGN stock, worth $5.28 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
16,400
Previous 3,600
355.56%
Holding current value
$5.28 Million
Previous $877,000
584185.06%
% of portfolio
0.42%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding AMGN
# of Institutions
3,082Shares Held
417MCall Options Held
7.24MPut Options Held
6.26M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.7 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.8 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.33 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.65 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.62 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $172B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...